Sutro Biopharma Stock Technical Analysis
| STRO Stock | USD 15.52 0.92 6.30% |
As of the 8th of February, Sutro Biopharma has the Risk Adjusted Performance of 0.0993, semi deviation of 5.21, and Coefficient Of Variation of 889.38. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sutro Biopharma, as well as the relationship between them.
Sutro Biopharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Sutro, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to SutroSutro Biopharma's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Sutro Biopharma Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 2.69 | Buy | 10 | Odds |
Most Sutro analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Sutro stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Sutro Biopharma, talking to its executives and customers, or listening to Sutro conference calls.
Will Biotechnology sector continue expanding? Could Sutro diversify its offerings? Factors like these will boost the valuation of Sutro Biopharma. If investors know Sutro will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Sutro Biopharma data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (2.60) | Revenue Per Share | Quarterly Revenue Growth 0.138 | Return On Assets | Return On Equity |
Understanding Sutro Biopharma requires distinguishing between market price and book value, where the latter reflects Sutro's accounting equity. The concept of intrinsic value - what Sutro Biopharma's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Sutro Biopharma's price substantially above or below its fundamental value.
Please note, there is a significant difference between Sutro Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sutro Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Sutro Biopharma's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Sutro Biopharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sutro Biopharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sutro Biopharma.
| 11/10/2025 |
| 02/08/2026 |
If you would invest 0.00 in Sutro Biopharma on November 10, 2025 and sell it all today you would earn a total of 0.00 from holding Sutro Biopharma or generate 0.0% return on investment in Sutro Biopharma over 90 days. Sutro Biopharma is related to or competes with Artiva Biotherapeutics, Precision BioSciences, Pliant Therapeutics, Fractyl Health, InflaRx NV, Metagenomi Common, and Connect Biopharma. Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company More
Sutro Biopharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sutro Biopharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sutro Biopharma upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.9 | |||
| Information Ratio | 0.0985 | |||
| Maximum Drawdown | 27.28 | |||
| Value At Risk | (7.78) | |||
| Potential Upside | 11.76 |
Sutro Biopharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sutro Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sutro Biopharma's standard deviation. In reality, there are many statistical measures that can use Sutro Biopharma historical prices to predict the future Sutro Biopharma's volatility.| Risk Adjusted Performance | 0.0993 | |||
| Jensen Alpha | 0.5922 | |||
| Total Risk Alpha | 0.077 | |||
| Sortino Ratio | 0.107 | |||
| Treynor Ratio | 0.4762 |
Sutro Biopharma February 8, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0993 | |||
| Market Risk Adjusted Performance | 0.4862 | |||
| Mean Deviation | 4.86 | |||
| Semi Deviation | 5.21 | |||
| Downside Deviation | 5.9 | |||
| Coefficient Of Variation | 889.38 | |||
| Standard Deviation | 6.41 | |||
| Variance | 41.14 | |||
| Information Ratio | 0.0985 | |||
| Jensen Alpha | 0.5922 | |||
| Total Risk Alpha | 0.077 | |||
| Sortino Ratio | 0.107 | |||
| Treynor Ratio | 0.4762 | |||
| Maximum Drawdown | 27.28 | |||
| Value At Risk | (7.78) | |||
| Potential Upside | 11.76 | |||
| Downside Variance | 34.84 | |||
| Semi Variance | 27.14 | |||
| Expected Short fall | (5.38) | |||
| Skewness | 0.4978 | |||
| Kurtosis | 0.9994 |
Sutro Biopharma Backtested Returns
Sutro Biopharma is unstable given 3 months investment horizon. Sutro Biopharma owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.2, which indicates the firm had a 0.2 % return per unit of risk over the last 3 months. We were able to interpolate data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.25% are justified by taking the suggested risk. Use Sutro Biopharma Risk Adjusted Performance of 0.0993, semi deviation of 5.21, and Coefficient Of Variation of 889.38 to evaluate company specific risk that cannot be diversified away. Sutro Biopharma holds a performance score of 15 on a scale of zero to a hundred. The entity has a beta of 1.49, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Sutro Biopharma will likely underperform. Use Sutro Biopharma sortino ratio, semi variance, as well as the relationship between the Semi Variance and rate of daily change , to analyze future returns on Sutro Biopharma.
Auto-correlation | 0.36 |
Below average predictability
Sutro Biopharma has below average predictability. Overlapping area represents the amount of predictability between Sutro Biopharma time series from 10th of November 2025 to 25th of December 2025 and 25th of December 2025 to 8th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sutro Biopharma price movement. The serial correlation of 0.36 indicates that just about 36.0% of current Sutro Biopharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.36 | |
| Spearman Rank Test | 0.39 | |
| Residual Average | 0.0 | |
| Price Variance | 3.73 |
Sutro Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Sutro Biopharma Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Sutro Biopharma volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Sutro Biopharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Sutro Biopharma on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Sutro Biopharma based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Sutro Biopharma price pattern first instead of the macroeconomic environment surrounding Sutro Biopharma. By analyzing Sutro Biopharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Sutro Biopharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Sutro Biopharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Interest Debt Per Share | 9.54 | 7.06 | 8.12 | 13.72 | Revenue Per Share | 25.55 | 8.08 | 9.29 | 8.82 |
Sutro Biopharma February 8, 2026 Technical Indicators
Most technical analysis of Sutro help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Sutro from various momentum indicators to cycle indicators. When you analyze Sutro charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0993 | |||
| Market Risk Adjusted Performance | 0.4862 | |||
| Mean Deviation | 4.86 | |||
| Semi Deviation | 5.21 | |||
| Downside Deviation | 5.9 | |||
| Coefficient Of Variation | 889.38 | |||
| Standard Deviation | 6.41 | |||
| Variance | 41.14 | |||
| Information Ratio | 0.0985 | |||
| Jensen Alpha | 0.5922 | |||
| Total Risk Alpha | 0.077 | |||
| Sortino Ratio | 0.107 | |||
| Treynor Ratio | 0.4762 | |||
| Maximum Drawdown | 27.28 | |||
| Value At Risk | (7.78) | |||
| Potential Upside | 11.76 | |||
| Downside Variance | 34.84 | |||
| Semi Variance | 27.14 | |||
| Expected Short fall | (5.38) | |||
| Skewness | 0.4978 | |||
| Kurtosis | 0.9994 |
Sutro Biopharma February 8, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Sutro stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.12 | ||
| Daily Balance Of Power | 0.47 | ||
| Rate Of Daily Change | 1.06 | ||
| Day Median Price | 15.26 | ||
| Day Typical Price | 15.34 | ||
| Price Action Indicator | 0.73 | ||
| Market Facilitation Index | 1.97 |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sutro Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. To learn how to invest in Sutro Stock, please use our How to Invest in Sutro Biopharma guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Will Biotechnology sector continue expanding? Could Sutro diversify its offerings? Factors like these will boost the valuation of Sutro Biopharma. If investors know Sutro will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Sutro Biopharma data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (2.60) | Revenue Per Share | Quarterly Revenue Growth 0.138 | Return On Assets | Return On Equity |
Understanding Sutro Biopharma requires distinguishing between market price and book value, where the latter reflects Sutro's accounting equity. The concept of intrinsic value - what Sutro Biopharma's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Sutro Biopharma's price substantially above or below its fundamental value.
Please note, there is a significant difference between Sutro Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sutro Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Sutro Biopharma's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.